Fire At Serum Institute Of India, Won’t Affect Covishield Production

0

Pune: A fire broke out today at the Serum Institute of India (SII) at an under-construction facility. However, it is unlikely to hit the production of Covishield, the coronavirus vaccine developed by the SII in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.

Massive efforts are on to put out the blaze, as per sources, NDTV reported.

Manjari, the complex where the fire broke out, is a few minutes drive from the facility where the COVID vaccines are produced, sources said. It is believed to be part of a Special Economic Zone (SEZ).

About eight-nine buildings are being constructed at the Manjari complex to deal with the future pandemics, aimed to enhance the SII’s manufacturing capability.

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.